IRMD
$102.80
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.
Intraday
Recent News
Why The IRADIMED (IRMD) Story Is Shifting As Analysts Update Targets And Guidance Arrives
IRADIMED’s updated analyst narrative now centers on a refreshed fair value estimate of US$120.0 per share, which aligns with the latest price target level. That change is being framed within Street research that has shifted in the same direction, with both more optimistic and more cautious voices updating their models around the new target. As you read on, you will see how to track these moving pieces and what to watch as the story continues to evolve. Stay updated as the Fair Value for...
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Here’s What Offers IRadimed Corp. (IRMD) a Compelling Growth Trajectory
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. US equities experienced solid returns in 2025, with double-digit gains across all major indices. A copy of the letter can be downloaded here. In 2025, the Conestoga Micro Cap Composite met its purpose of preserving capital during negative market returns and capturing upside […]
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter
This medical device firm supplies MRI-compatible equipment to healthcare providers through direct sales and a specialized network.
Resolute Holdings Stock Soars 400% as Nine Ten Trims $5 Million From Stake
This New York alternative asset manager delivers tailored investment solutions and reported notable profitability in its latest filing.